Frontiers in Immunology | Cancer Immunity and Immunotherapy

Case Report

Published on 27 Jan 2023

Case report: Advanced primary squamous cell carcinoma in the periampullary area with upregulation of programmed cell death-ligand 1 expression and response to sintilimab immunotherapy

in Cancer Immunity and Immunotherapy

Baoshan Wang
Dazhou Li
Dehua Zeng
Wen Wang
Chuanshen Jiang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1086760

1,618 views
3 citations

Original Research

Published on 27 Jan 2023

By integrating single-cell RNA-seq and bulk RNA-seq in sphingolipid metabolism, CACYBP was identified as a potential therapeutic target in lung adenocarcinoma

in Cancer Immunity and Immunotherapy

Pengpeng Zhang
Shengbin Pei
Zeitian Gong
Yanlong Feng
Xiao Zhang
Fang Yang
Wei Wang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1115272

7,706 views
41 citations

Review

Published on 27 Jan 2023

T lymphocyte cell: A pivotal player in lung cancer

in Cancer Immunity and Immunotherapy

Yanan Wu
Meng Yuan
Chenlin Wang
Yanfei Chen
Yan Zhang
Jiandong Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1102778

11,483 views
24 citations

Review

Published on 27 Jan 2023

The ectonucleotidases CD39 and CD73 on T cells: The new pillar of hematological malignancy

in Cancer Immunity and Immunotherapy

Xuan Jiang
Xiaofang Wu
Yuxi Xiao
Penglin Wang
Jiamian Zheng
Xiuli Wu
Zhenyi Jin

Frontiers in Immunology

doi 10.3389/fimmu.2023.1110325

8,217 views
32 citations

Original Research

Published on 27 Jan 2023

Incorporation of a TGF-β2-inhibiting oligodeoxynucleotide molecular adjuvant into a tumor cell lysate vaccine to enhance antiglioma immunity in mice

in Cancer Immunity and Immunotherapy

Liqun Tu
Zhe Wang
Lei Yang
Xiaomeng Sun
Yunpeng Yao
Peng Zhang
Xiaotian Zhang
Liying Wang
Yongli Yu
Ming Yang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1013342

3,463 views
2 citations

Review

Published on 27 Jan 2023

Immunotherapy with immune checkpoint inhibitors and predictive biomarkers in malignant mesothelioma: Work still in progress

in Cancer Immunity and Immunotherapy

Matteo Perrino
Fabio De Vincenzo
Nadia Cordua
Federica Borea
Marta Aliprandi
Armando Santoro
Paolo Andrea Zucali

Frontiers in Immunology

doi 10.3389/fimmu.2023.1121557

7,386 views
16 citations

Systematic Review

Published on 27 Jan 2023

Meta-analysis of neoadjuvant immunotherapy for non-metastatic colorectal cancer

in Cancer Immunity and Immunotherapy

Long Zhou
Xiao-Quan Yang
Guang-yue Zhao
Feng-jian Wang
Xin Liu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1044353

13,669 views
17 citations

Original Research

Published on 27 Jan 2023

NCAPG2 could be an immunological and prognostic biomarker: From pan-cancer analysis to pancreatic cancer validation

in Cancer Immunity and Immunotherapy

Qi Wang
Zhangzuo Li
Shujing Zhou
Zhengrui Li
Xufeng Huang
Yiwei He
Yuhan Zhang
Xiaoxian Zhao
Yidan Tang
Min Xu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1097403

20,989 views
26 citations

Original Research

Published on 27 Jan 2023

Follicle-like tertiary lymphoid structures: A potential biomarker for prognosis and immunotherapy response in patients with laryngeal squamous cell carcinoma

in Cancer Immunity and Immunotherapy

Haifeng Liang
Zhigang Zhang
Zhong Guan
Shibie Zheng
Jintao Lou
Wei Liu
Qian Cai
Yu Si

Frontiers in Immunology

doi 10.3389/fimmu.2023.1096220

4,996 views
19 citations

Original Research

Published on 26 Jan 2023

Decreased monocyte-to-lymphocyte ratio was associated with satisfied outcomes of first-line PD-1 inhibitors plus chemotherapy in stage IIIB-IV non-small cell lung cancer

in Cancer Immunity and Immunotherapy

Liang Zheng
Anning Xiong
Shuyuan Wang
Jianlin Xu
Yinchen Shen
Runbo Zhong
Jun Lu
Tianqing Chu
Wei Zhang
Ying Li

Frontiers in Immunology

doi 10.3389/fimmu.2023.1094378

3,897 views
17 citations

Systematic Review

Published on 26 Jan 2023

Do proton pump inhibitors alter the response to immune checkpoint inhibitors in cancer patients? A meta-analysis

in Cancer Immunity and Immunotherapy

Sébastien Lopes
Lucile Pabst
Anne Dory
Marion Klotz
Bénédicte Gourieux
Bruno Michel
Céline Mascaux

Frontiers in Immunology

doi 10.3389/fimmu.2023.1070076

12,496 views
31 citations

Mini Review

Published on 26 Jan 2023

gC1qR: A New Target for Cancer Immunotherapy

in Cancer Immunity and Immunotherapy

Yanna Lei
Xiaoyu Li
Diyuan Qin
Yugu Zhang
Yongsheng Wang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1095943

6,092 views
10 citations

Original Research

Published on 26 Jan 2023

RUNX1/CD44 axis regulates the proliferation, migration, and immunotherapy of gliomas: A single-cell sequencing analysis

in Cancer Immunity and Immunotherapy

Hao Zhang
Hui Cao
Hong Luo
Nan Zhang
Zeyu Wang
Ziyu Dai
Wantao Wu
Guodong Liu
Zongyi Xie
Quan Cheng

Frontiers in Immunology

doi 10.3389/fimmu.2023.1086280

5,788 views
8 citations

Original Research

Published on 26 Jan 2023

DOG1 as a novel antibody-drug conjugate target for the treatment of multiple gastrointestinal tumors and liver metastasis

in Cancer Immunity and Immunotherapy

Yangping Wu
Wenting Li
Xiangzheng Chen
Haichuan Wang
Siyuan Su
Ying Xu
Xiangbing Deng
Tinghan Yang
Mingtian Wei
Li Li

Frontiers in Immunology

doi 10.3389/fimmu.2023.1051506

5,696 views
4 citations

Original Research

Published on 25 Jan 2023

Identification of tumor antigens and immune landscapes for bladder urothelial carcinoma mRNA vaccine

in Cancer Immunity and Immunotherapy

Zhuolun Sun
Changying Jing
Hailun Zhan
Xudong Guo
Ning Suo
Feng Kong
Wen Tao
Chutian Xiao
Daoyuan Hu
Hanbo Wang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1097472

4,757 views
9 citations

Original Research

Published on 25 Jan 2023

Multi-omics profiling and digital image analysis reveal the potential prognostic and immunotherapeutic properties of CD93 in stomach adenocarcinoma

in Cancer Immunity and Immunotherapy

Baokang Wu
Lei Fu
Xingqi Guo
Huixin Hu
Yang Li
Yu Shi
Yizhou Zhang
Shukun Han
Chao Lv
Yu Tian

Frontiers in Immunology

doi 10.3389/fimmu.2023.984816

8,578 views
8 citations